The increase in liver fat in the carriers of the PNPLA3 I148M gene variant is due to polyunsaturated triglycerides, whereas in “Obese/Metabolic NAFLD” the concentration of saturated triglycerides and insulin resistance-inducing ceramides is increased [14]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.